Investigating long-term lung effects of severe COVID-19
COVID-19 Lung Microvascular and Parenchymal Sequelae (Lung-MaPS)
This study is looking at how severe COVID-19 can affect lung health over time, using special imaging to see any damage in the lungs, so we can better support people recovering from serious cases of the virus.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10828399 on NIH RePORTER |
What this research studies
This research focuses on understanding the long-term health impacts of severe COVID-19 on lung function. By utilizing advanced imaging techniques, the study aims to identify and describe the vascular and parenchymal damage that may occur in COVID-19 survivors. The research involves assessing pulmonary blood volume and lung tissue characteristics through dual-energy computed tomography (CT) to provide insights into recovery or progression of lung conditions over time. The findings will help improve post-hospitalization care for individuals affected by severe COVID-19.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who have experienced severe COVID-19 and are currently receiving post-hospitalization care.
Not a fit: Patients who have not had severe COVID-19 or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better management and treatment strategies for COVID-19 survivors experiencing lung complications.
How similar studies have performed: Other research has shown promising results in understanding lung complications from COVID-19 using imaging techniques, indicating that this approach is both relevant and potentially impactful.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Oelsner, Elizabeth — Columbia University Health Sciences
- Study coordinator: Oelsner, Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.